Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Induced Labor No Costlier than Spontaneous Labor

By HospiMedica International staff writers
Posted on 22 May 2019
A new study calculates that inducing labor at 39 weeks costs healthcare systems the same as waiting for spontaneous labor.

Researchers at the University of Utah (Salt Lake City, USA) and Intermountain Medical Center (IMC; Salt Lake City, UT, USA) conducted a multicenter study in the state of Utah involving 1,230 low-risk, nulliparous mothers, in order to measure actual cost differences to healthcare facilities between inducing labor one week early and waiting for spontaneous, natural labor. More...
Among study participants, 608 women were induced at 39 weeks and 622 experienced spontaneous labor.

The results of the study confirmed that contrary to common belief, the increased cost accrued from women spending more time in the hospital after inducing labor is offset by cost saved from avoiding additional tests, visits and medications later in pregnancy, as well as serious health outcomes, such as preeclampsia. In addition, the researchers found that inducing labor at 39 weeks reduced the rate of Cesarean section in new mothers. The study was presented at the annual meeting of the American College of Obstetricians and Gynecologists (ACPG), held during May 2019 in Nashville (TN, USA).

“We watched real patients as they went through the system to evaluate the actual costs for randomized patients for clinical outcomes. We found that the increase in cost from other parts of patient care cancel out those costs,” said lead author and study presenter Brett Einerson, MD, MPH, of the University of Utah. “This is a conclusion that is totally opposite of what we in obstetrics have assumed over the past 30 years. While the study is focused on Utah hospitals, the results are applicable across the country.”

“These results demonstrate the importance of considering cost in the medical decisions that we make,” said study co-author maternal fetal medicine physician Sean Esplin, MD, of Intermountain Healthcare. “This is a unique study that could only be accomplished in Utah. Intermountain Healthcare and the University of Utah are interested in providing the highest quality of care at the lowest price possible, so we are constantly tracking costs, which makes a study like this possible."

Related Links:
University of Utah
Intermountain Medical Center


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.